A Jahodova1, P Krsek2, M Kyncl3, P Jezdik4, M Kudr5, V Komarek6, P Jayakar7, I Miller8, T Resnick9, M Duchowny10. 1. Department of Pediatric Neurology, Charles University, Second Medical School, Motol University Hospital, V Uvalu 84, Prague 5 150 06, Czech Republic. Electronic address: a.jagoda@email.cz. 2. Department of Pediatric Neurology, Charles University, Second Medical School, Motol University Hospital, V Uvalu 84, Prague 5 150 06, Czech Republic. Electronic address: pavel.krsek@post.cz. 3. Department of Radiology, Charles University, Second Medical School, Motol University Hospital, V Uvalu 84, Prague 5 150 06, Czech Republic. Electronic address: martinkyn@seznam.cz. 4. Department of Measurement, Faculty of Electric, Czech Technical University Prague, Technicka 2, CZ 166 27 Prague 6, Czech Republic. Electronic address: jezdip1@feld.cvut.cz. 5. Department of Pediatric Neurology, Charles University, Second Medical School, Motol University Hospital, V Uvalu 84, Prague 5 150 06, Czech Republic. Electronic address: mat.kudr@gmail.com. 6. Department of Pediatric Neurology, Charles University, Second Medical School, Motol University Hospital, V Uvalu 84, Prague 5 150 06, Czech Republic. Electronic address: vladimir.komarek@fnmotol.cz. 7. Department of Neurology and Comprehensive Epilepsy Program, Brain Institute, Miami Children's Hospital, 3200 S.W. 60th Court, Miami, FL, United States. Electronic address: Prasanna.Jayakar@mch.com. 8. Department of Neurology and Comprehensive Epilepsy Program, Brain Institute, Miami Children's Hospital, 3200 S.W. 60th Court, Miami, FL, United States. Electronic address: ian.miller@mchdocs.com. 9. Department of Neurology and Comprehensive Epilepsy Program, Brain Institute, Miami Children's Hospital, 3200 S.W. 60th Court, Miami, FL, United States; Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, United States. Electronic address: trevor.resnick@mch.com. 10. Department of Neurology and Comprehensive Epilepsy Program, Brain Institute, Miami Children's Hospital, 3200 S.W. 60th Court, Miami, FL, United States; Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, United States. Electronic address: michael.duchowny@mch.com.
Abstract
OBJECTIVE: Localization of the epileptogenic zone (EZ) is challenging in children with tuberous sclerosis complex (TSC). We sought to ascertain whether brain MRI could identify the EZ in TSC patients independent of the clinical and diagnostic data. METHODS: Presurgical MRI's of 34 children with TSC who underwent epilepsy surgery at Miami Children's Hospital were retrospectively reevaluated by experts blinded to all other data. Changes typical of TSC (tubers, calcifications, cystic changes) and abnormalities of the perituberal cortex typical of focal cortical dysplasia (FCD) (increased cortical thickness, abnormal gyration, transmantle change, gray/white matter junction blurring) were identified and their localization was compared with the resection site. Sensitivity, specificity and accuracy of individual MRI features to localize the EZ were determined and statistically compared between postoperatively seizure-free and non-seizure-free patients as well as clusters of features typical of FCD and TSC. RESULTS: MRI alone correctly localized the resection cavity in all 19 postoperatively seizure-free patients and 12 of 15 non-seizure-free subjects. Sensitivity, specificity and accuracy of MRI features typical of FCD to localize EZ (90%, 96% and 96%, respectively) were superior to those typical of TCS (79%, 75% and 75%, p<0.0001). Increased cortical thickness and abnormal gyral formation outside tubers occurred only in the resection site. Resection sites were better predicted by MRI in seizure-free than in non-seizure-free patients. CONCLUSION: Thorough MRI evaluation identifies the EZ in a significant proportion of TSC patients. Epileptogenic regions were mostly characterized by "FCD-like" changes outside cortical tubers. The findings may have important practical consequences for surgical planning in TSC.
OBJECTIVE: Localization of the epileptogenic zone (EZ) is challenging in children with tuberous sclerosis complex (TSC). We sought to ascertain whether brain MRI could identify the EZ in TSC patients independent of the clinical and diagnostic data. METHODS: Presurgical MRI's of 34 children with TSC who underwent epilepsy surgery at Miami Children's Hospital were retrospectively reevaluated by experts blinded to all other data. Changes typical of TSC (tubers, calcifications, cystic changes) and abnormalities of the perituberal cortex typical of focal cortical dysplasia (FCD) (increased cortical thickness, abnormal gyration, transmantle change, gray/white matter junction blurring) were identified and their localization was compared with the resection site. Sensitivity, specificity and accuracy of individual MRI features to localize the EZ were determined and statistically compared between postoperatively seizure-free and non-seizure-free patients as well as clusters of features typical of FCD and TSC. RESULTS: MRI alone correctly localized the resection cavity in all 19 postoperatively seizure-free patients and 12 of 15 non-seizure-free subjects. Sensitivity, specificity and accuracy of MRI features typical of FCD to localize EZ (90%, 96% and 96%, respectively) were superior to those typical of TCS (79%, 75% and 75%, p<0.0001). Increased cortical thickness and abnormal gyral formation outside tubers occurred only in the resection site. Resection sites were better predicted by MRI in seizure-free than in non-seizure-free patients. CONCLUSION: Thorough MRI evaluation identifies the EZ in a significant proportion of TSC patients. Epileptogenic regions were mostly characterized by "FCD-like" changes outside cortical tubers. The findings may have important practical consequences for surgical planning in TSC.
Authors: Shai Shrot; Misun Hwang; Carl E Stafstrom; Thierry A G M Huisman; Bruno P Soares Journal: Neuroradiology Date: 2017-12-26 Impact factor: 2.804
Authors: Alexander A Sosunov; Robert A McGovern; Charles B Mikell; Xiaoping Wu; David G Coughlin; Peter B Crino; Howard L Weiner; Saadi Ghatan; James E Goldman; Guy M McKhann Journal: Acta Neuropathol Commun Date: 2015-04-02 Impact factor: 7.801
Authors: Angelika Mühlebner; Jackelien van Scheppingen; Hanna M Hulshof; Theresa Scholl; Anand M Iyer; Jasper J Anink; Ans M W van den Ouweland; Mark D Nellist; Floor E Jansen; Wim G M Spliet; Pavel Krsek; Barbora Benova; Josef Zamecnik; Peter B Crino; Daniela Prayer; Thomas Czech; Adelheid Wöhrer; Jasmin Rahimi; Romana Höftberger; Johannes A Hainfellner; Martha Feucht; Eleonora Aronica Journal: PLoS One Date: 2016-06-13 Impact factor: 3.240
Authors: Angelika Mühlebner; Jackelien van Scheppingen; Andrew de Neef; Anika Bongaarts; Till S Zimmer; James D Mills; Floor E Jansen; Wim G M Spliet; Pavel Krsek; Josef Zamecnik; Roland Coras; Ingmar Blumcke; Martha Feucht; Theresa Scholl; Victoria-Elisabeth Gruber; Johannes A Hainfellner; Figen Söylemezoğlu; Katarzyna Kotulska; Lieven Lagae; Anna C Jansen; David J Kwiatkowski; Sergiusz Jozwiak; Paolo Curatolo; Eleonora Aronica Journal: J Neuropathol Exp Neurol Date: 2020-10-01 Impact factor: 3.685
Authors: Hanna M Hulshof; Barbora Benova; Pavel Krsek; Martin Kyncl; Maarten H Lequin; Anezka Belohlavkova; Petr Jezdik; Kees P J Braun; Floor E Jansen Journal: Epilepsia Open Date: 2021-08-06